Compound Monograph
S-Allylcysteine
S-allylcysteine (SAC) is the stable, odorless, water-soluble organosulfur compound that accumulates as garlic is aged, and the standardization marker for aged garlic extract. Unlike allicin and the reactive garlic sulfides it is chemically stable and highly bioavailable — a heavily studied preclinical antioxidant/neuroprotectant whose human cardiovascular evidence belongs to the whole extract, not the isolate.
Sources · 3
Where Does It Come From?
S-Allylcysteine is a naturally occurring organosulfur compound (water-soluble cysteine derivative), found in Garlic — chiefly aged garlic extract and 2 other sources. It is well tolerated orally (low toxicity).
Concentration
Content by Source
Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.
S-Allylcysteine at a Glance
S-allylcysteine (SAC) is the stable, odourless, water-soluble organosulfur compound that accumulates as garlic is aged, and the standardisation marker for aged garlic extract.
It is the opposite of allicin in every practical respect. Allicin and the reactive garlic sulfides are pungent, unstable and formed only when a clove is crushed; SAC is stable, well absorbed and odourless, which is why aged garlic extract can be standardised to it while raw-garlic products cannot be standardised to allicin.
That makes it the most measurable and reproducible of garlic’s actives.
What It's Used For
S-allylcysteine (SAC) is the odorless, water-soluble organosulfur compound that accumulates as garlic is aged, and it is the standardization marker for aged garlic extract (AGE). Its defining feature separates it from the rest of garlic’s chemistry: unlike allicin, ajoene and the diallyl sulfides — which are reactive, unstable and poorly bioavailable — SAC is chemically stable and highly bioavailable 4,
(It is also distinct from alliin, its oxidized sulfoxide precursor.) That stability makes it both a good research molecule and the reason AGE is standardized to it. Its most-developed pharmacology is preclinical antioxidant and neuroprotective activity via the Nrf2/ARE antioxidant program 5,
The key honesty point runs through the whole page: the human cardiovascular evidence is for aged garlic extract standardized to SAC, not for isolated SAC — SAC is the measuring stick, not proven to be the active agent.
Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Isolated-SAC efficacy is preclinical and the human data are whole-extract, so isolate scores stay low by design. Each application links to its write-up.
SAC’s most-developed application. It scavenges radicals and activates the Nrf2/ARE antioxidant program, raising SOD, catalase and glutathione peroxidase in striatum, cortex and hippocampus, preserving BDNF, and protecting neurons in excitotoxicity, ischemia and mitochondrial-dysfunction models 5,
Gap: entirely preclinical for neurological endpoints — there are no human neurodegeneration or stroke trials of SAC (or AGE) at clinical endpoints, and the effects are shown at injected or high oral rodent doses 5,
Aged garlic extract, standardized to SAC as its marker, modestly lowers blood pressure in hypertensives, nudges serum cholesterol, improves endothelial function in men with coronary disease, and slowed subclinical atherosclerosis progression 16,
Gap: this human evidence is for the whole aged extract, not SAC in isolation — SAC is the standardization handle, not proven the active moiety, and the atherosclerosis trial added B-vitamins, folate and L-arginine 17,
SAC reduced porcine-serum-induced hepatic fibrosis in rats 10Reference 10AnimalS-allylcysteine is effective as a chemopreventive agent against porcine-serum-induced hepatic fibrosis in ratsView study →, protected HepG2 cells from peroxide injury via Akt/Nrf2/HO-1 11Reference 11S-allylcysteine alleviates hydrogen-peroxide-induced oxidative injury and apoptosis through Akt/Nrf-2/HO-1 in HepG2 cellsView study →, and attenuated free-fatty-acid lipogenesis via AMPK 12Reference 12S-allylcysteine attenuates free-fatty-acid-induced lipogenesis in human HepG2 cells through an AMPK-dependent pathwayView study →; a double-blind RCT of fermented garlic extract lowered elevated GGT in adults 20Reference 20RCTEfficacy and safety of fermented garlic extract on hepatic function: a double-blind, randomised, placebo-controlled trialView study →.
Gap: mechanistic/animal for the isolate, and the only human liver trial used fermented garlic extract — a related preparation, not isolated SAC 11,
SAC induced apoptosis and oxidative cytotoxicity in lung cancer lines (downregulating Nrf2/NF-κB and suppressing PD-L1) 14Reference 14S-allylcysteine induces cytotoxic effects in two human lung cancer cell lines via downregulation of Nrf2 and NF-κB and apoptosisView study → and inhibited tumor progression and epithelial-mesenchymal transition in an oral-cancer mouse xenograft 15Reference 15AnimalS-allylcysteine inhibits tumour progression and the epithelial-mesenchymal transition in a mouse xenograft model of oral cancerView study →, with a review cataloguing diverse mechanisms 13Reference 13Garlic-derived bioactive compound S-allylcysteine inhibits cancer progression through diverse molecular mechanismsView study →.
Gap: no human oncology data at all — effects are in-vitro or a single xenograft, so this is speculative 13,
SAC suppressed hepatic lipogenesis in an AMPK-dependent manner in HepG2 cells 12Reference 12S-allylcysteine attenuates free-fatty-acid-induced lipogenesis in human HepG2 cells through an AMPK-dependent pathwayView study →.
Gap: thin — one cell model that overlaps the hepatoprotective story, with no whole-animal metabolic-endpoint or human data for isolated SAC 12Reference 12S-allylcysteine attenuates free-fatty-acid-induced lipogenesis in human HepG2 cells through an AMPK-dependent pathwayView study →.
Mechanisms
| Target / pathway | Effect | Relevant to |
|---|---|---|
| Nrf2/ARE → ↑ SOD, catalase, GSH-Px, HO-1 | endogenous antioxidant-enzyme induction | neuroprotectionhepatoprotection |
| Direct radical/ROS scavenging | ↓ lipid peroxidation, mitochondrial protection | excitotoxic and metabolic-stress models |
| NF-κB modulation | ↓ inflammatory signaling; pro-apoptotic in tumor cells | anti-inflammatoryanticancer |
| AMPK activation | ↓ hepatic lipogenesis | metabolic/hepatic |
| H₂S / NO modulation, endothelial function (AGE context) | vasorelaxation, blood-pressure effect | cardiovascular |
Pharmacokinetics
This is SAC’s strongest point of difference from every reactive garlic sulfur compound. It is well absorbed and stable: oral bioavailability is ~64% in mouse, ~89% in rat and ~98% in dog 1Reference 1Pharmacokinetics of the garlic compound S-allylcysteineView study →, with a modern rat/dog study confirming rapid, near-complete absorption 2Reference 2AnimalMetabolism, excretion and pharmacokinetics of S-allyl-L-cysteine in rats and dogsView study →. It is odorless, water-soluble and not degraded like allicin, so it is measurable in plasma and tissue — which is precisely why AGE is standardized to it 4,
Clinical trials
There are no controlled human trials of isolated SAC. All human data are for aged garlic extract standardized to SAC: reviews and meta-analyses of AGE for blood pressure and cholesterol 16,
| Completed | Planned | Terminated | Preclinical |
|---|---|---|---|
| —(isolate); AGE RCTs/meta-analyses | — | — | Extensive |
Last checked: July 2026.
Toxicity & Safety
SAC has very low toxicity — a genuinely safe compound, markedly less toxic than allicin and its reactive congeners, with a high margin of safety in rodent work (roughly an order of magnitude less toxic than allicin or diallyl disulfide) 4,
Dosage
There is no isolated-SAC human dose, and nothing here is a recommendation. Cardiovascular trials use aged garlic extract at roughly 600–1200 mg AGE/day 16Reference 16Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol and stimulates immunityView study →; the meta-analysis that reported significant benefit only above ~1200 mg/day has been retracted 17Reference 17Meta-analysisEffects of aged garlic extract on blood pressure in hypertensive patients: a systematic review and meta-analysisView study →, so no threshold within that range is established. AGE products are standardized to a stated SAC content rather than dosed as free SAC, so these regimens deliver only milligram quantities of SAC embedded in a whole extract.
References
- Nagae S, et al. (1994). Pharmacokinetics of the garlic compound S-allylcysteine. Planta Medica. https://pubmed.ncbi.nlm.nih.gov/8073085/
- Amano H, et al. (2015). Metabolism, excretion and pharmacokinetics of S-allyl-L-cysteine in rats and dogs. Drug Metabolism and Disposition. https://pubmed.ncbi.nlm.nih.gov/25681129/
- Nakamoto M, Kunimura K, Ohtani M (2025). Pharmacokinetics of sulfur-containing compounds in aged garlic extract (review). Experimental and Therapeutic Medicine. https://pubmed.ncbi.nlm.nih.gov/40171136/
- Kodera Y, Suzuki A, Imada O, et al. (2002). Physical, chemical and biological properties of S-allylcysteine, an amino acid derived from garlic. Journal of Agricultural and Food Chemistry. https://pubmed.ncbi.nlm.nih.gov/11804540/
- Colín-González AL, Ali SF, Túnez I, et al. (2015). On the antioxidant, neuroprotective and anti-inflammatory properties of S-allylcysteine: an update. Neurochemistry International. https://pubmed.ncbi.nlm.nih.gov/26122973/
- Colín-González AL, Santana RA, Silva-Islas CA, et al. (2012). The antioxidant mechanisms underlying the aged-garlic-extract- and S-allylcysteine-induced protection. Oxidative Medicine and Cellular Longevity. https://pubmed.ncbi.nlm.nih.gov/22685624/
- Shi H, Jing X, Wei X, et al. (2015). S-allylcysteine activates the Nrf2-dependent antioxidant response and protects neurons against ischemic injury in vitro and in vivo. Journal of Neurochemistry. https://pubmed.ncbi.nlm.nih.gov/25393425/
- Reyes-Soto CY, Rangel-López E, Galván-Arzate S, et al. (2020). S-allylcysteine protects against excitotoxic damage via Nrf2/ARE binding and BDNF preservation. Neurotoxicity Research. https://pubmed.ncbi.nlm.nih.gov/32813208/
- Pérez-De La Cruz V, González-Cortés C, Pedraza-Chaverrí J, et al. (2006). Protective effect of S-allylcysteine on 3-nitropropionic-acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes. Brain Research Bulletin. https://pubmed.ncbi.nlm.nih.gov/16377446/
- Shinkawa H, Takemura S, Minamiyama Y, et al. (2009). S-allylcysteine is effective as a chemopreventive agent against porcine-serum-induced hepatic fibrosis in rats. Osaka City Medical Journal. https://pubmed.ncbi.nlm.nih.gov/20088405/
- Basu C, Sur R (2018). S-allylcysteine alleviates hydrogen-peroxide-induced oxidative injury and apoptosis through Akt/Nrf-2/HO-1 in HepG2 cells. BioMed Research International. https://pubmed.ncbi.nlm.nih.gov/30515391/
- Hwang YP, Kim HG, Choi JH, et al. (2013). S-allylcysteine attenuates free-fatty-acid-induced lipogenesis in human HepG2 cells through an AMPK-dependent pathway. Journal of Nutritional Biochemistry. https://pubmed.ncbi.nlm.nih.gov/23465592/
- Agbana YL, Ni Y, Zhou M, et al. (2020). Garlic-derived bioactive compound S-allylcysteine inhibits cancer progression through diverse molecular mechanisms. Nutrition Research. https://pubmed.ncbi.nlm.nih.gov/31835095/
- Orozco-Morales M, Hernández-Pedro NY, Barrios-Bernal P, et al. (2021). S-allylcysteine induces cytotoxic effects in two human lung cancer cell lines via downregulation of Nrf2 and NF-κB and apoptosis. Anti-Cancer Drugs. https://pubmed.ncbi.nlm.nih.gov/33136700/
- Pai MH, Kuo YH, Chiang EP, et al. (2012). S-allylcysteine inhibits tumour progression and the epithelial-mesenchymal transition in a mouse xenograft model of oral cancer. British Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/22011514/
- Ried K, et al. (2016). Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol and stimulates immunity. The Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/26764326/
- Saadh MJ, et al. (2024). Effects of aged garlic extract on blood pressure in hypertensive patients: a systematic review and meta-analysis. Prostaglandins & Other Lipid Mediators. https://pubmed.ncbi.nlm.nih.gov/39437887/ ⚠ RETRACTED — retraction notice: Prostaglandins Other Lipid Mediat. 2026, https://pubmed.ncbi.nlm.nih.gov/42527229/
- Williams MJ, Sutherland WH, McCormick MP, et al. (2005). Aged garlic extract improves endothelial function in men with coronary artery disease. Phytotherapy Research. https://pubmed.ncbi.nlm.nih.gov/16041725/
- Budoff MJ, Ahmadi N, Gul KM, et al. (2009). Aged garlic extract supplemented with B-vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomised clinical trial. Preventive Medicine. https://pubmed.ncbi.nlm.nih.gov/19573556/
- Kim HN, Kang SG, Roh YK, et al. (2017). Efficacy and safety of fermented garlic extract on hepatic function: a double-blind, randomised, placebo-controlled trial. European Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/27743130/
- Mikaili P, Maadirad S, Moloudizargari M, et al. (2013). Therapeutic uses and pharmacological properties of garlic, shallot and their biologically active compounds. Iranian Journal of Basic Medical Sciences. https://pubmed.ncbi.nlm.nih.gov/24379960/
